Lilly has signed a deal with CureVac to develop up to five next-generation cancer vaccines which use messenger RNA (mRNA) technology. While previous cancer vaccines approaches have disappointed ...

GSK has upgraded its longstanding alliance with CureVac on mRNA-based vaccines for respiratory infections, paying €400 million ($429 million) upfront for global rights to its influenza and COVID ...

NVAX claimed that this vaccine uses a new approach for immunizing against the virus. Last month, CureVac announced that it has started a phase I/II study on its bird flu vaccine. CureVac is ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Shares of several vaccine makers soared after reports suggest that the Biden administration is in discussions with Moderna MRNA and Pfizer PFE to set up a possible vaccine program aimed at preventing ...

In response to the reports, shares of Moderna, Pfizer, Novavax NVAX, CureVac CVAC and BioNTech rose 13.7%, 3.6%, 5.3%, 18.8% and 11.1%, respectively, on Wednesday. Some vaccine makers mentioned ...

At close: April 17 at 4:00:01 PM EDT ...

This data feed is not available at this time.